Consolidated Statement of Changes in Equity - CAD ($) $ in Millions |
Total |
Contributed surplus [member] |
Retained earnings [member] |
Accumulated other comprehensive income [member] |
Accumulated other comprehensive income [member]
Reserve of cash flow hedges [member]
|
Accumulated other comprehensive income [member]
Reserve of change in fair value of financial liability attributable to change in credit risk of liability [member]
|
Accumulated other comprehensive income [member]
Reserve of exchange differences on translation [member]
|
Accumulated other comprehensive income [member]
Financial assets at fair value through other comprehensive income [member]
|
Accumulated other comprehensive income [member]
Equity securities at fair value through other comprehensive income [member]
|
Common shares [member]
Retained earnings [member]
|
Common shares [member]
Issued capital [member]
|
Common shares [member]
Treasury shares [member]
|
Preferred shares and other equity instruments [member] |
Preferred shares and other equity instruments [member]
Retained earnings [member]
|
Preferred shares and other equity instruments [member]
Issued capital [member]
|
Preferred shares and other equity instruments [member]
Treasury shares [member]
|
| Balance at beginning of period at Oct. 31, 2024 |
|
$ 204
|
$ 70,826
|
|
$ (2,924)
|
$ (22)
|
$ 12,893
|
$ (208)
|
$ 35
|
|
$ 25,373
|
$ (17)
|
|
|
$ 10,888
|
$ (18)
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of stock options, net of options exercised |
|
3
|
|
|
|
|
|
|
|
|
69
|
|
|
|
|
|
| Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
130
|
|
|
|
|
|
| Issue of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
750
|
|
| Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
(436)
|
|
|
|
|
|
| Purchase of shares |
|
|
|
|
|
|
|
|
|
|
|
(6,384)
|
|
|
|
(1,387)
|
| Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(500)
|
|
| Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
6,375
|
|
|
|
1,377
|
| Net premium (discount) on sale of treasury instruments |
|
(11)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other |
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income attributable to equity instrument holders |
|
|
13,922
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
$ (3,651)
|
|
|
|
$ (286)
|
|
|
| Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
(2,135)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share and other equity instrument issue expenses |
|
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remeasurement gain/(loss) on employee benefit plans |
$ (11)
|
|
(11)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
(23)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(144)
|
|
|
|
|
|
|
(145)
|
|
|
|
|
|
|
|
|
| Allowance for credit losses |
1
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
24
|
|
|
|
|
|
|
|
| Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
21
|
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(512)
|
|
|
|
|
|
(512)
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
1,846
|
|
|
|
1,846
|
|
|
|
|
|
|
|
|
|
|
|
| Share of accumulated other comprehensive income (loss) from investment in Schwab |
1,870
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at end of period at Apr. 30, 2025 |
126,091
|
199
|
78,640
|
$ 11,032
|
(1,078)
|
(1)
|
12,381
|
(352)
|
82
|
|
25,136
|
(26)
|
$ 11,138
|
|
11,138
|
(28)
|
| Balance at beginning of period at Jan. 31, 2025 |
|
189
|
71,718
|
|
(2,719)
|
(29)
|
15,529
|
(99)
|
46
|
|
25,528
|
(38)
|
|
|
11,138
|
(51)
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of stock options, net of options exercised |
|
3
|
|
|
|
|
|
|
|
|
44
|
|
|
|
|
|
| Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
| Issue of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
| Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
(436)
|
|
|
|
|
|
| Purchase of shares |
|
|
|
|
|
|
|
|
|
|
|
(2,880)
|
|
|
|
(267)
|
| Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
| Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
2,892
|
|
|
|
290
|
| Net premium (discount) on sale of treasury instruments |
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other |
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income attributable to equity instrument holders |
|
|
11,129
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
(1,815)
|
|
|
|
(200)
|
|
|
| Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
(2,135)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share and other equity instrument issue expenses |
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remeasurement gain/(loss) on employee benefit plans |
(29)
|
|
(29)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
(28)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(253)
|
|
|
|
|
|
|
(255)
|
|
|
|
|
|
|
|
|
| Allowance for credit losses |
2
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
| Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
28
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
28
|
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(3,148)
|
|
|
|
|
|
(3,148)
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
1,641
|
|
|
|
1,641
|
|
|
|
|
|
|
|
|
|
|
|
| Share of accumulated other comprehensive income (loss) from investment in Schwab |
2,208
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at end of period at Apr. 30, 2025 |
126,091
|
199
|
78,640
|
11,032
|
(1,078)
|
(1)
|
12,381
|
(352)
|
82
|
|
25,136
|
(26)
|
11,138
|
|
11,138
|
(28)
|
| Balance at beginning of period at Oct. 31, 2025 |
127,827
|
285
|
78,320
|
|
(769)
|
(28)
|
13,242
|
283
|
146
|
|
24,727
|
0
|
|
|
11,625
|
(4)
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of stock options, net of options exercised |
|
40
|
|
|
|
|
|
|
|
|
150
|
|
|
|
|
|
| Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
| Issue of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
| Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
(568)
|
|
|
|
|
|
| Purchase of shares |
|
|
|
|
|
|
|
|
|
|
|
(6,213)
|
|
|
|
(515)
|
| Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
| Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
6,153
|
|
|
|
505
|
| Net premium (discount) on sale of treasury instruments |
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other |
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income attributable to equity instrument holders |
|
|
8,294
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
(3,597)
|
|
|
|
(303)
|
|
|
| Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
(4,483)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share and other equity instrument issue expenses |
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remeasurement gain/(loss) on employee benefit plans |
28
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
55
|
|
|
|
|
|
|
54
|
|
|
|
|
|
|
|
|
| Allowance for credit losses |
1
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
60
|
|
|
|
|
|
|
|
| Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
(35)
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(3)
|
|
|
|
|
(3)
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(1,899)
|
|
|
|
|
|
(1,899)
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(1,250)
|
|
|
|
(1,250)
|
|
|
|
|
|
|
|
|
|
|
|
| Share of accumulated other comprehensive income (loss) from investment in Schwab |
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at end of period at Apr. 30, 2026 |
124,318
|
361
|
78,295
|
9,802
|
(2,019)
|
(31)
|
11,343
|
338
|
171
|
|
24,309
|
(60)
|
11,625
|
|
11,625
|
(14)
|
| Balance at beginning of period at Jan. 31, 2026 |
|
315
|
78,253
|
|
(1,215)
|
(41)
|
11,430
|
527
|
167
|
|
24,551
|
(5)
|
|
|
11,625
|
(11)
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of stock options, net of options exercised |
|
27
|
|
|
|
|
|
|
|
|
42
|
|
|
|
|
|
| Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
| Issue of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
| Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
(284)
|
|
|
|
|
|
| Purchase of shares |
|
|
|
|
|
|
|
|
|
|
|
(2,899)
|
|
|
|
(353)
|
| Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
| Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
2,844
|
|
|
|
350
|
| Net premium (discount) on sale of treasury instruments |
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other |
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income attributable to equity instrument holders |
|
|
4,251
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
$ (1,786)
|
|
|
|
$ (202)
|
|
|
| Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
(2,321)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share and other equity instrument issue expenses |
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remeasurement gain/(loss) on employee benefit plans |
78
|
|
78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(189)
|
|
|
|
|
|
|
(189)
|
|
|
|
|
|
|
|
|
| Allowance for credit losses |
0
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
25
|
|
|
|
|
|
|
|
| Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
(21)
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
10
|
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(87)
|
|
|
|
|
|
(87)
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(804)
|
|
|
|
(804)
|
|
|
|
|
|
|
|
|
|
|
|
| Share of accumulated other comprehensive income (loss) from investment in Schwab |
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at end of period at Apr. 30, 2026 |
$ 124,318
|
$ 361
|
$ 78,295
|
$ 9,802
|
$ (2,019)
|
$ (31)
|
$ 11,343
|
$ 338
|
$ 171
|
|
$ 24,309
|
$ (60)
|
$ 11,625
|
|
$ 11,625
|
$ (14)
|